Secondary childhood acute myeloid leukemia with complex karyotypic anomalies including monosomy 7, monosomy 5 and translocation (1;10) after 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma
The prognosis for relapsing or refractory neuroblastoma (NB) remains dismal, with a five-year disease-free survival of < 20%, and no effective salvage treatment has been identified so far. 131I-metaiodobenzylguanidine (131I-MIBG) has come to play an essential role in the imaging and therapy o...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hacettepe University Institute of Child Health
2011-02-01
|
| סדרה: | The Turkish Journal of Pediatrics |
| גישה מקוונת: | https://turkjpediatr.org/article/view/1726 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|